KPIs & Operating Metrics(New)
Growth Metrics

Clover Health Investments (CLOV) Net Cash Flow (2020 - 2025)

Clover Health Investments' Net Cash Flow history spans 6 years, with the latest figure at -$111.8 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 9.27% year-over-year to -$111.8 million; the TTM value through Dec 2025 reached -$116.2 million, down 744.04%, while the annual FY2025 figure was -$116.2 million, 744.04% down from the prior year.
  • Net Cash Flow reached -$111.8 million in Q4 2025 per CLOV's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $312.2 million in Q1 2021 to a low of -$297.3 million in Q4 2022.
  • Average Net Cash Flow over 5 years is -$5.7 million, with a median of $35.9 million recorded in 2024.
  • The largest YoY upside for Net Cash Flow was 3634.86% in 2021 against a maximum downside of 1503.41% in 2021.
  • A 5-year view of Net Cash Flow shows it stood at $97.7 million in 2021, then tumbled by 404.32% to -$297.3 million in 2022, then skyrocketed by 41.06% to -$175.2 million in 2023, then surged by 41.64% to -$102.3 million in 2024, then decreased by 9.27% to -$111.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Net Cash Flow are -$111.8 million (Q4 2025), $1.4 million (Q3 2025), and $33.2 million (Q2 2025).